scholarly article | Q13442814 |
P2093 | author name string | Hee Yeon Won | |
Sun-Kyeong Lee | |||
Se Hwan Mun | |||
Paula Hernandez | |||
Hector Leonardo Aguila | |||
P2860 | cites work | Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 | Q24300916 |
MIF signal transduction initiated by binding to CD74 | Q24303802 | ||
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex | Q24307384 | ||
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 | ||
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 | Q28138425 | ||
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia | Q28265011 | ||
Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis | Q28267970 | ||
Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase | Q28278061 | ||
The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor | Q28285539 | ||
RANKL-RANK signaling in osteoclastogenesis and bone disease | Q28287091 | ||
Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor | Q28297046 | ||
Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression | Q28585705 | ||
Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action | Q28594433 | ||
Osteoclast differentiation and activation | Q29547556 | ||
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 | ||
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
Polarized expression of CD74 by gastric epithelial cells | Q30414247 | ||
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte | Q33858422 | ||
Evolution of the CD8 T-cell repertoire during infections | Q34019945 | ||
Differentiation and function of osteoclasts | Q35113943 | ||
Modulation of osteoclast differentiation | Q35957509 | ||
Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice | Q35992094 | ||
Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments | Q36236708 | ||
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors | Q36375584 | ||
Advances in bone biology: the osteoclast | Q36825193 | ||
CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract | Q37234000 | ||
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation | Q37286240 | ||
NFATc1: functions in osteoclasts | Q37662853 | ||
Guidelines for assessment of bone microstructure in rodents using micro-computed tomography | Q37763651 | ||
CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease | Q37826194 | ||
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos | Q38342636 | ||
Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator | Q38363724 | ||
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity | Q40169158 | ||
Participation of phospholipase D and alpha/beta-protein kinase C in growth factor-induced signalling in C3H10T1/2 fibroblasts | Q40643082 | ||
Regulation of osteoclastogenesis and RANK expression by TGF-beta1. | Q40778414 | ||
Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens | Q41376430 | ||
Alterations of macrophage functions by mediators from lymphocytes | Q41815135 | ||
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation | Q42475736 | ||
Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. | Q42479982 | ||
Bifurcation of osteoclasts and dendritic cells from common progenitors | Q43757343 | ||
Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. | Q43864464 | ||
The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors | Q44480297 | ||
Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity | Q46669596 | ||
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. | Q53636101 | ||
RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production. | Q53647336 | ||
Macrophage migration inhibitory factor inhibits osteoclastogenesis. | Q54473878 | ||
The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice. | Q54662060 | ||
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development | Q70459353 | ||
Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes | Q71775766 | ||
Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts | Q71868864 | ||
CFU-GM-derived cells form osteoclasts at a very high efficiency | Q73445414 | ||
Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures | Q74472384 | ||
Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide | Q74518854 | ||
Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis | Q77857409 | ||
Identification of multiple osteoclast precursor populations in murine bone marrow | Q81628327 | ||
P433 | issue | 4 | |
P304 | page(s) | 948-959 | |
P577 | publication date | 2013-04-01 | |
P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
P1476 | title | Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass | |
P478 | volume | 28 |
Q37702522 | A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice. |
Q41576045 | CD74-Downregulation of Placental Macrophage-Trophoblastic Interactions in Preeclampsia |
Q47373904 | Clinically Relevant Concentrations of Ketamine Inhibit Osteoclast Formation In Vitro in Mouse Bone Marrow Cultures |
Q33912625 | Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo |
Q46260785 | DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation |
Q34788649 | Effects of salubrinal on development of osteoclasts and osteoblasts from bone marrow-derived cells |
Q36489227 | Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption |
Q35790946 | Knee loading protects against osteonecrosis of the femoral head by enhancing vessel remodeling and bone healing |
Q39848278 | Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions |
Q46274917 | Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis. |
Q30586409 | Macrophage migration inhibitory factor down-regulates the RANKL-RANK signaling pathway by activating Lyn tyrosine kinase in mouse models |
Q91026071 | Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling |
Q35163701 | Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis |
Q53225768 | Psychosine inhibits osteoclastogenesis and bone resorption via G protein-coupled receptor 65. |
Q55226585 | Regulation of Osteoclast Differentiation by Cytokine Networks. |
Q33894821 | eIF2α signaling regulates ischemic osteonecrosis through endoplasmic reticulum stress |
Search more.